Related Experiment Videos
Dual-energy X-ray absorptiometry and body composition
1MRC Dunn Nutritional Laboratory, Cambridge, UK.
Nutrition (Burbank, Los Angeles County, Calif.)
|January 1, 1996
Summary
Dual-energy absorptiometry (DXA) is a safe and precise method for assessing bone density and body composition. However, accuracy issues between manufacturers limit its use as a gold standard for body composition analysis.
Area of Science:
- Radiology
- Medical Imaging
- Bone Densitometry
Background:
- Dual-energy absorptiometry (DXA) is a widely used clinical tool for osteoporosis risk assessment and therapy monitoring.
- DXA is increasingly employed for body composition analysis, measuring fat and fat-free mass.
- Three major manufacturers (Lunar, Hologic, Norland) produce DXA instruments.
Purpose of the Study:
- To review the advantages and limitations of dual-energy absorptiometry (DXA).
- To discuss the clinical applications of DXA in bone mineral content and body composition assessment.
- To highlight the accuracy and precision issues associated with different DXA systems.
Main Methods:
- DXA systems utilize X-rays at two different energies to differentiate bone and soft tissue.
- Measurements are typically taken at the spine, hip, and forearm, with specialized systems offering whole-body scans.
- The review synthesizes information on DXA technology, clinical use, and performance characteristics.
Main Results:
- DXA offers excellent precision, particularly in healthy subjects, with low radiation exposure making it safe for all age groups.
- Accuracy can be problematic due to systematic differences between manufacturers' systems (calibration, bone edge detection).
- Variations in manufacturer reference data can lead to discrepancies in patient risk assessment.
Conclusions:
- DXA is a valuable, safe, and precise technique for bone density and body composition, but accuracy limitations persist.
- Differences between DXA systems and reference data currently prevent its designation as a "gold standard" for body composition.
- Ongoing technological advancements and software development are enhancing DXA's performance and clinical utility.